Aridis Pharmaceuticals In... (ARDS)
undefined
undefined%
At close: undefined
0.00
-99.00%
Pre-market Oct 07, 2024, 09:30 AM EDT

Aridis Pharmaceuticals Statistics

Share Statistics

Aridis Pharmaceuticals has 44.57M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 44.57M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 37.29M
Failed to Deliver (FTD) Shares 8.00K
FTD / Avg. Volume 48.46%

Short Selling Information

The latest short interest is 2.00M, so 4.5% of the outstanding shares have been sold short.

Short Interest 2.00M
Short % of Shares Out 4.5%
Short % of Float 5.37%
Short Ratio (days to cover) 0.22

Valuation Ratios

The PE ratio is -0.72 and the forward PE ratio is null.

PE Ratio -0.72
Forward PE null
PS Ratio 0
Forward PS null
PB Ratio -0.91
P/FCF Ratio -0.76
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Aridis Pharmaceuticals Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.32, with a Debt / Equity ratio of -0.18.

Current Ratio 0.32
Quick Ratio 0.32
Debt / Equity -0.18
Total Debt / Capitalization -21.57
Cash Flow / Debt -6.77
Interest Coverage -79.35

Financial Efficiency

Return on equity (ROE) is 1.27% and return on capital (ROIC) is 167.75%.

Return on Equity (ROE) 1.27%
Return on Assets (ROA) -2.09%
Return on Capital (ROIC) 167.75%
Revenue Per Employee 0
Profits Per Employee -831.05K
Employee Count 37
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 378.00K
Effective Tax Rate -0.01

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is -26.04, so Aridis Pharmaceuticals 's price volatility has been lower than the market average.

Beta -26.04
52-Week Price Change null%
50-Day Moving Average 0
200-Day Moving Average 0.03
Relative Strength Index (RSI) 48.31
Average Volume (20 Days) 16.51K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -29.99M
Net Income -30.75M
EBITDA -29.51M
EBIT n/a
Earnings Per Share (EPS) -1.64
Full Income Statement

Balance Sheet

The company has 4.88M in cash and 6.13M in debt, giving a net cash position of -1.25M.

Cash & Cash Equivalents 4.88M
Total Debt 6.13M
Net Cash -1.25M
Retained Earnings -195.67M
Total Assets 6.53M
Working Capital -13.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -29.13M and capital expenditures -82.00K, giving a free cash flow of -29.21M.

Operating Cash Flow -29.13M
Capital Expenditures -82.00K
Free Cash Flow -29.21M
FCF Per Share -1.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ARDS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield -655351.13%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ARDS.

Price Target $2
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -40.63
Piotroski F-Score 4